Androgen receptor involvement in the progression of prostate cancer.
H Suzuki, T Ueda, T Ichikawa… - Endocrine-related cancer, 2003 - erc.bioscientifica.com
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
Androgen receptor involvement in the progression of prostate cancer
H Suzuki, T Ueda, T Ichikawa… - Endocrine-related …, 2003 - pubmed.ncbi.nlm.nih.gov
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
Androgen receptor involvement in the progression of prostate cancer.
H Suzuki, T Ueda, T Ichikawa, H Ito - Endocrine-related Cancer, 2003 - europepmc.org
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
[PDF][PDF] Androgen receptor involvement in the progression of prostate cancer
H Suzuki, T Ueda, T Ichikawa, H Ito - Endocrine-Related Cancer, 2003 - scholar.archive.org
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
Androgen receptor involvement in the progression of prostate cancer
H Suzuki, T Ueda, T Ichikawa, H Ito - Endocrine-Related Cancer, 2003 - hero.epa.gov
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
[PDF][PDF] Androgen receptor involvement in the progression of prostate cancer
H Suzuki, T Ueda, T Ichikawa, H Ito - Endocrine-Related Cancer, 2003 - Citeseer
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
Androgen receptor involvement in the progression of prostate cancer.
H Suzuki, T Ueda, T Ichikawa, H Ito - Endocrine-related cancer, 2003 - cir.nii.ac.jp
抄録< jats: p> Since the growth of prostate cancer is androgen-sensitive, metastatic disease
has been treated by hormonal therapy. Almost all prostate cancer patients initially respond …
has been treated by hormonal therapy. Almost all prostate cancer patients initially respond …
Androgen receptor involvement in the progression of prostate cancer
H Suzuki, T Ueda, T Ichikawa… - Endocrine-Related …, 2003 - erc.bioscientifica.com
Since the growth of prostate cancer is androgen-sensitive, metastatic disease has been
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
treated by hormonal therapy. Almost all prostate cancer patients initially respond to …
[引用][C] Androgen receptor involvement in the progression of prostate cancer
H SUZUKI - Endocr. Relat. Cancer, 2003 - cir.nii.ac.jp